Patient approval of insulin therapy in type 2 diabetic patients.

摘要

The primary goal of therapy in diabetes mellitus is to reach and sustain near-normal glycemic levels to prevent acute metabolic complications.1 When insulin is initiated early in the disease process, this therapy has the potential to preserve beta-cell function and delay disease progression.2'3 However, the discomfort and inconvenience of self injection are significant deterrents, to many patients.